or Try an Advanced Search...

    ETF Components for HELX - Franklin Genomic Advancements ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    VRTX D -0.73 5.94
    KRYS C -0.29 4.70
    NTRA A -1.01 4.64
    LLY F -1.52 4.63
    REGN F 0.06 4.30
    MEDP F 0.00 4.07
    TMO D -0.64 4.01
    DHR D -0.81 3.99
    UTHR C -0.09 2.75
    AZN F 0.84 2.34
    CDNS B 0.04 2.34
    CTVA C 0.78 2.29
    CRL D -0.03 2.23
    BNTX D 0.41 2.21
    A F 1.21 2.11
    IONS F -0.59 2.10
    INSM C -1.32 2.08
    RVTY D 0.71 2.01
    ALNY D 0.33 1.98
    QGEN D 0.31 1.96
    BRKR F -0.28 1.94
    SRPT F -0.43 1.50
    RARE F 0.00 1.46
    RCKT F -1.04 1.42
    TWST F -1.54 1.27
    LGND C 0.92 1.27
    ICLR D 1.10 1.25
    EXAS D -0.47 1.20
    LH B -1.09 1.15
    IQV F -0.11 1.08
    RGEN D -1.20 1.08
    BEAM D -1.80 1.03
    TECH F 0.46 1.01
    VYGR F -1.40 0.99
    AZTA D 2.45 0.95
    NBIX C -0.33 0.94
    BBIO F 0.68 0.91
    RXRX D -2.98 0.69
    MRNA F -1.30 0.66
    BIO C 0.00 0.59
    VCYT B -0.23 0.56
    DVAX C 0.49 0.53
    NTLA F 4.69 0.51
    DOCS C 0.47 0.51
    CDMO A 0.66 0.51
    CRSP D -2.20 0.50
    AVTR F -0.55 0.46
    BMY B -0.55 0.36
    CRNX B -0.56 0.25
    BMRN F -0.90 0.20
    ARE F 0.30 0.15
    SLP F 1.12 0.11
    FDMT F -5.11 0.10

    Represented by ETF Holdings

    Keywords: Biotechnology S&P 500 Life Sciences Biology Biopharmaceutical Medicine Cancer Clinical Development Acid Drug Discovery Infectious Diseases Lab Testing Amyloid Antibodies Cholesterol In Vitro Nasdaq 100 Rare Diseases Amyloidosis Asthma
    Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Agricultural Inputs Health Information Services Health Information Services REIT - Office Semiconductor Equipment & Materials Software - Application Specialty Chemicals

    Recent News for Franklin Genomic Advancements ETF & its Holdings

    Date Stock Title
    Nov 21 TECH Temu Parent PDD Stock Tumbles After Q3 Profit Miss, Company Cites Intensified Competition and External Challenges
    Nov 21 TECH How To Earn $500 A Month From Intuit Stock Ahead Of Q1 Earnings
    Nov 21 AZN We Think AstraZeneca's (LON:AZN) Healthy Earnings Might Be Conservative
    Nov 21 LLY Eli Lilly, Verge announce milestones in ALS collaboration
    Nov 21 AZN 3 Growth Stocks Trading Near Their 52-Week Lows to Buy Right Now
    Nov 21 TECH Tesla Registrations Drop By Over 20% In October In EU, Possibly Hindering Its 2024 Global EV Delivery Target
    Nov 21 AZN AstraZeneca upgraded to Neutral from Sell at UBS
    Nov 21 AZN AstraZeneca price target lowered to EUR 140 from EUR 150 at Berenberg
    Nov 21 TECH SpaceX CEO Elon Musk Reveals Technical Glitch That Led Company To Drop Key Objective Of Starship's 6th Test Flight
    Nov 21 TECH Ray Dalio Says Pro-Trump Tech Companies Stand To Gain As Focus Shifts To Deregulation: Here's How Investors Should Brace For Impact
    Nov 21 TECH SafeRent Settles $2.3M Discrimination Lawsuit Over Alleged AI Screening Bias Against Low-Income Renters
    Nov 21 TECH Google's 'Unlawful Behavior' Stifles Market Entry For Rivals: DOJ Says Alphabet Must Sell Chrome To End Search Monopoly
    Nov 21 TECH Tesla Now Allows Users To Report Snow Accumulation, Blocked Stalls And Other Supercharger Issues Ahead Of Winter
    Nov 21 LLY Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
    Nov 21 TECH Why SpaceX Opted For Standard Starship Landing Over Elon Musk's Innovative 'Chopsticks' Technique
    Nov 21 TECH Ford's JV Battery Plant In Kentucky Faces Unionization As 'Supermajority' Of Workers Sign Union Authorization Cards, Says UAW
    Nov 21 TECH Nvidia's Blackwell Set To Outpace Hopper? Here's What CEO Jensen Huang Predicts For 2025
    Nov 21 TECH Elon Musk's Neuralink Gets Green Light To Launch Brain Chip Trial In Canada: 'Recruitment Is Now Open'
    Nov 21 TECH Nvidia CEO Jensen Huang Says The Present Time Is 'The Beginnings Of Two Fundamental Shifts In Computing' As Blackwell Powers Explosive AI Demand
    Nov 21 CRSP CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript)
    Seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life. Provides access to companies benefitting from or facilitating the use of new research including DNA sequencing, gene editing and personalized medicine Uses bottom-up fundamental research conducted by dedicated, industry-specific analysts to identify disruptive business models at the right stage for investment Actively managed by a seasoned portfolio management team that is based in Silicon Valley and has a long history of investing in the craft of innovation
    Exchange Traded Fund ETF Biotechnology Life Sciences Biology Emerging Technologies Molecular Biology Genetics Portfolio Management Quality Of Life Personalized Medicine DNA DNA Sequencing
    Back to the Main HELX Page...